Works matching IS 1025496X AND DT 2024 AND VI 29 AND IP 15

Results: 3

Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.
Published in:
Eurosurveillance (15607917), 2024, v. 29, n. 15, p. 1, doi. 10.2807/1560-7917.ES.2024.29.15.2300352
By:
- Lasarte-Monterrubio, Cristina;
- Guijarro-Sánchez, Paula;
- Alonso-Garcia, Isaac;
- Outeda, Michelle;
- Maceiras, Romina;
- González-Pinto, Lucia;
- Martínez-Guitián, Marta;
- Fernández-Lozano, Carlos;
- Carlos Vázquez-Ucha, Juan;
- Bou, German;
- Arca-Suárez, Jorge;
- Beceiro, Alejandro
Publication type:
Article
Emergence of OXA-48-like producing Citrobacter species, Germany, 2011 to 2022.
Published in:
Eurosurveillance (15607917), 2024, v. 29, n. 15, p. 1, doi. 10.2807/1560-7917.ES.2024.29.15.2300528
By:
- Sommer, Julian;
- Reiter, Hannah;
- Sattler, Janko;
- Cacace, Elisabetta;
- Eisfeld, Jessica;
- Gatermann, Sören;
- Hamprecht, Axel;
- Göttig, Stephan
Publication type:
Article
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.
Published in:
Eurosurveillance (15607917), 2024, v. 29, n. 15, p. 1, doi. 10.2807/1560-7917.ES.2024.29.15.2400178
By:
- Nørgaard, Sarah K.;
- Nielsen, Jens;
- Nordholm, Anne Christine;
- Richter, Lukas;
- Chalupka, Alena;
- Bustos Sierra, Natalia;
- Braeye, Toon;
- Athanasiadou, Maria;
- Lytras, Theodore;
- Denissov, Gleb;
- Luomala, Oskari;
- Fouillet, Anne;
- Pontais, Isabelle;
- An der Heiden, Matthias;
- Zacher, Benedikt;
- Weigel, Alina;
- Foppa, Ivo;
- Gkolfinopoulou, Kassiani;
- Panagoulias, Ioannis;
- Paldy, Anna
Publication type:
Article

Works matching IS 1025496X AND DT 2024 AND VI 29 AND IP 15

Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.

Emergence of OXA-48-like producing Citrobacter species, Germany, 2011 to 2022.

Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.